Mild cognitive impairment is the intermediate stage between the normal cognitive decline seen with aging and the more serious decline of dementia. A recent pilot study suggests that a drink containing a mix of omega-3s and mixed botanicals may have...
A recent study suggests that people who develop depression and mild cognitive impairment after the age of 65 are more likely to have accelerated brain aging, putting them at higher risk for dementia. The study also found that older adults...
High levels of plasma total homocysteine (tHcy) have been linked with cerebral atrophy of brain regions related to cognitive decline and Alzheimer's disease. A recent study suggests that taking high doses of vitamin B may lower mean plasma tHcy levels...
Mild cognitive impairment (MCI) is the cognitive stage at which memory and other mental functions begin to decline. A recent study suggests that supplementation with omega-3s may lower oxidative stress, potentially slowing the advancement of MCI. Participants in the study...
Previous research has suggested that vitamin E levels may be related to the risk of Alzheimer's disease. A recent study sought to verify that the use of MRI brain scans together with measurements of plasma blood levels of all forms...
A recent study suggests that supplementation with all eight forms of vitamin E may noticeably reduce the risk of developing mild cognitive impairment, an ailment that can lead to Alzheimer's disease. The study found that the risk of mild cognitive...
